Cell and Gene Therapy Catapult’s Post

Navigating the evolving landscape of approved cell and gene therapies poses a challenge for the drug development community. Discover insights on aligning expectations and implementing effective bioanalytical strategies in our latest eBook. For more in-depth knowledge, explore our new Cell and Gene Therapy Accelerating Science Feature: https://lnkd.in/ea6_b8_v #genetherapy, #celltherapy, and #drugdevelopment. #AAPS #BiotechInsights

Are you attending the International Society for Cell & Gene Therapy's (ISCT) Europe Regional Meeting in #Sweden? ➡️ https://buff.ly/4fnNGon Hear from Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult who will be speaking across the day sharing expert commentary into regulatory standards, the current use of iPSCs, and commercial development of cell and gene therapies. #CellTherapies #GeneTherapies

It's almost here! On Friday the EMMA International team will be releasing a new White Paper on February 16th: "CRISPR Technology and its Impact on the Regulatory Landscape." As researchers explore the potential of CRISPR in the development of gene therapies, the regulatory landscape becomes a critical aspect of ensuring the safety and efficacy of these groundbreaking treatments. In this White Paper, we will delve into how the FDA navigates and regulates CRISPR technology in the context of gene therapy. Click the link here to explore our expansive library of White Papers: https://lnkd.in/eA7YDkDc

It's almost here! On Friday the EMMA International team will be releasing a new White Paper on February 16th: "CRISPR Technology and its Impact on the Regulatory Landscape." As researchers explore the potential of CRISPR in the development of gene therapies, the regulatory landscape becomes a critical aspect of ensuring the safety and efficacy of these groundbreaking treatments. In this White Paper, we will delve into how the FDA navigates and regulates CRISPR technology in the context of gene therapy. Click the link here to explore our expansive library of White Papers: https://lnkd.in/eA7YDkDc

Exciting News in Cell and Gene Therapy! 🧬 Check out our insightful editorial feature on the latest advancements in the field, exploring some revolutionary breakthroughs!

We are quickly approaching an inflection point with respect to using cell therapies to treat #autoimmune disease. While we have increasing confidence that cell therapies will play a pivotal role in the treatment of autoimmune disorders, sponsors will have to overcome significant barriers to deliver on this promise: reducing manufacturing costs, expanding treatment infrastructure, improving the risk/benefit profile, to name just a few. Curious to learn more? Check out our blog post and presentation at #ISCT2024 by Health Advances Cell and Gene Therapy practice co-leader Ned Wydysh PhD, and Jamie Pierson of Parexel. Read our blog here: https://bit.ly/3yZzelC ISCT, International Society for Cell & Gene Therapy #CGT #CellandGene

Today the EMMA International team released a new White Paper: "CRISPR Technology and its Impact on the Regulatory Landscape." As researchers explore the potential of CRISPR in the development of gene therapies, the regulatory landscape becomes a critical aspect of ensuring the safety and efficacy of these groundbreaking treatments. In this White Paper, we will delve into how the FDA navigates and regulates CRISPR technology in the context of gene therapy. Click the link here to download your copy: https://lnkd.in/eCZsbYDq

It's almost here! Tomorrow the EMMA International team will be releasing a new White Paper on February 16th: "CRISPR Technology and its Impact on the Regulatory Landscape." As researchers explore the potential of CRISPR in the development of gene therapies, the regulatory landscape becomes a critical aspect of ensuring the safety and efficacy of these groundbreaking treatments. In this White Paper, we will delve into how the FDA navigates and regulates CRISPR technology in the context of gene therapy. Click the link here to explore our expansive library of White Papers: https://lnkd.in/eA7YDkDc

Gain insights on our take on how we solve three main challenges in advancing cell and gene therapies to clinic. Join Qian(Sarah) Li, PhD, EMBA to learn about how #plasmid DNA serves essential roles as critical materials for cell and gene therapy applications and various key considerations including emerging methods for yield improvement, characterization and quality control. #celltherapy #genetherapy

It's almost here! On Friday the EMMA International team will be releasing a new White Paper on February 16th: "CRISPR Technology and its Impact on the Regulatory Landscape." As researchers explore the potential of CRISPR in the development of gene therapies, the regulatory landscape becomes a critical aspect of ensuring the safety and efficacy of these groundbreaking treatments. In this White Paper, we will delve into how the FDA navigates and regulates CRISPR technology in the context of gene therapy. Click the link here to explore our expansive library of White Papers: https://lnkd.in/eA7YDkDc